Save the date: Optimum’s 19th Annual Healthcare Investor Conference — 7 October 2027. We look forward to seeing you there! 📸 Were you there? Find your photos and have your say! Find your photos, download your favourites and share them on social media, and don’t forget to tag Optimum so we can see them too. […]
AC Immune First Half 2026 Financial and Corporate Update AC Immune SA (NASDAQ: ACIU), a clinical-stage biopharmaceutical company developing targeted therapeutics for neurodegenerative diseases, provided a corporate and financial update for the half-year ended June 30, 2026. The period saw strong advances across the Company’s pipeline, with its partnered programs generating considerable milestone payments as […]
Transcript: Isabelle Abdou: Hi, and welcome to the Optimum Perspectives podcast. I’m Isabelle Abdou, and in this latest episode, we’ll be exploring women’s health, what’s really changing in the science, the capital behind it, and what still needs to shift. To explore it, I’m joined by three leading biotech executives and a seasoned healthcare investor. […]
Drum roll… In Vivo’s 2026 Rising Leaders were announced this week and included not one, not two, but five Optimum clients. A huge congratulations to Colleen Acosta of Freya Biosciences, Diana Čekatauskaitė of Lonza’s Synaffix, Reuben Dawkins of Link Biologics, Michelle Morrow of Nucleome Therapeutics, and Javier Nunez-Vicandi of Sofinnova Partners. This list recognises not […]
If a good rule of thumb for a conference is how full the hall is at the end of the day compared to the start, then the 21st Anglonordic Life Science Conference held last Thursday, attended by well over 300 people, was a resounding success. Maybe it was still full because attendees were keen to […]
